"The wicketkeeper-batsman had inadvertently ingested the prohibited substance, as a contaminant of a weight loss product he was taking, Hydroxycut," the ICC said in a statement.
The 29-year-old Shazad, who has played 58 ODIs and as many T20s for his country, breached article 2.1 of the ICC Anti-Doping Code.
"Mr Shahzad had provided a urine sample as part of the ICC's out-of-competition testing programme in Dubai, UAE, on 17 January 2017," the ICC stated.
His sample was subsequently tested and found to contain clenbuterol. Clenbuterol is classified as a non-Specified Substance by WADA and is prohibited both in-competition and out-of-competition.
The ICC, however, accepted Shahzad's explanation that he had inadvertently ingested the substance, as a contaminant of a weight loss product he was taking, Hydroxycut.
"Mr Shahzad was able to satisfy the ICC through evidence and submissions prepared on his behalf that he had no intention to enhance his sporting performance through the use of prohibited substances...," the ICC said.
"It further serves as a reminder to all international cricketers of the dangers and risks associated with taking supplements," Allardice said.
"Before thinking about taking a supplement, cricketers should weigh up the risks and dangers of doing so and should fully research the supplement in question so they can make an informed decision," he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
